At Caligor Coghlan Pharma Services, we make it our business to find a better way, often overcoming physical and regulatory barriers, to chart new and improved pathways to meet our client’s pharma service needs.
Caligor Coghlan Pharma Services’ deep and diverse history began when Caligor Rx was founded as a retail pharmacy in New York City
Caligor Rx evolved to provide clinical trial services for comparators and ancillary products assisting our clients with global clinical trials
Caligor Rx added pre-approval access/early access program support to its menu of services after identifying a gap in the market for a high-touch, full-service model
Diversis Capital, a Los Angeles-based private equity group, acquired Caligor Rx and renamed the company Caligor Opco. This significant business change and the associated investment afforded Caligor Opco the opportunity to expand and enhance services for our clients.
Caligor Opco acquired The Coghlan Group (est. 1996), a specialty packaging and labeling company located outside of Austin, Texas. Through this acquisition, Caligor Opco expanded our service offerings to include secondary packaging and labeling.
The organization was renamed Caligor Coghlan Pharma Services.
premier, global provider of pharma services.
Our services include clinical trial design, clinical packaging and labeling, IMP management and global distribution, commercial and ancillary product procurement, Clinical Supply Management, Early Access to Medicines services, strategic Regulatory consulting, commercialized product distribution, and asset acquisition planning.
Partner with pharmaceutical, biotechnology, and medical device clients to help bring new, life changing medical products and treatments to markets across the world.
Caligor Coghlan Pharma Services will be the preferred partner for clients expecting high-touch, premier pharma services